Navigation Links
BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy
Date:8/6/2014

RALEIGH, N.C., Aug. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has completed a pre-specified interim analysis of the ongoing initial pivotal Phase 3 trial for Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN).

The interim analysis was performed on data from the first 50% of patients who completed the study. The purpose of the interim analysis was to allow for a sample size adjustment if necessary to maintain appropriate statistical power to detect a treatment effect between Clonidine Topical Gel and placebo. 

BDSI views the outcome of the analysis as very encouraging.  As a result of the interim analysis, a total of approximately 80 additional patients will be added to the ongoing trial in an effort to maintain 90% percent power to detect a statistically significant difference between Clonidine Topical Gel and placebo.  The analysis was executed by an independent biostatistician.

"We are encouraged by the outcome of the interim analysis," stated Dr. Andrew Finn, Executive Vice President of Product Development at BDSI. "The additional patients not only allow us to maintain the probability of ultimately meeting the study's endpoints, but given that the initial study enrollment was about three months ahead of schedule, we still anticipate having top-line results by the end of the first quarter of 2015.  In addition, the expanded sample size will provide an adequate number of subjects to complete the required long-term safety study that will be part of our NDA package.  Also part of the NDA will be a second pivotal trial that we anticipate starting in early 2015."

"The outcome of the interim analysis is significant because it utilized actual study data to make a sample size adjustment to main
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
2. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
3. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
4. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
5. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
6. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
7. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
8. BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference
9. BioDelivery Sciences Announces $40 Million Registered Financing
10. BioDelivery Sciences Announces Completion of BNX Safety Study
11. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 According ... Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, ... Manifold, & Rotary) & Geography - Global Trends ... and segments the lyophilization market on the basis ... and projections of the market size of each ...
(Date:9/19/2014)... 19, 2014  Lpath, Inc. (NASDAQ: ... therapeutics, announced today that it has entered into ... common stock and 3,605,042 unregistered warrants in a ... one registered share of common stock and one ... common stock will be $3.475.  The warrants have ...
(Date:9/19/2014)... 19, 2014 Aufgrund der ... äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die ... verfügbar unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen ... in Kraft treten. Für international tätige ... um das "ob", sondern darum, "wann" sie die ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new ... exam life insurance plan provides for vulnerable family members. ... should be a top priority for every provider. It ... taking medical examinations and visiting a doctor. , ... will provide coverage up to $300,000, but only to ...
(Date:9/20/2014)... The festival season is coming soon. The high-end fashion ... cocktail dresses . A lot of sophisticated women like ... a new promotion for its high quality clothes. Now, each ... from 20 to 71 percent off. , The company’s ... are provided in many fashionable colors. Mary, the company’s sales ...
(Date:9/20/2014)... September 20, 2014 As concerns ... ) in gynecological surgeries continue to grow, ... has announced plans to end coverage for uterine ... website last month, Harrisburg, Pennsylvania-based Capital BlueCross will ... 2014. The insurer said its decision was prompted ...
(Date:9/20/2014)... The excitement is building up once again for ... This year the Surry Arts Council will be celebrating its ... country who are still fans of the Andy Griffith Show. ... aired on CBS from 1960 through 1968. The show ranked ... history. Mount Airy, North Carolina is where the show was ...
(Date:9/20/2014)... 2014 Recently, UWDress.com, an innovative company ... special occasion outfits, has launched a special offer for ... outfits are popular among worldwide clients. Now, all the ... prom dresses on its website. , Additionally, the ... around the world. Great custom made items can be ...
Breaking Medicine News(10 mins):Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2
... treatments, help may be right around the corner . A ... gain back their fertility -- even after going into menopause ... cause a woman to experience premature menopause and diminish her ... froze a 30-year-old woman’s ovarian tissue to determine if they ...
... United States, is linked to obesity and lack of exercise. It ... properly to metabolize food, especially sugar. Type-I or juvenile diabetes is ... ,In a recent study of 14,600 people, it was ... had nearly an 80 percent lowered risk, while men who drank ...
... the estrogen pills do not reduce the risk of heart ... ,Researchers say their results show estrogen alone does ... disease as combination hormone therapy is believed to do. Estrogen ... developing breast cancer. Researchers say the hormone does appear to ...
... new study shows eating dietary fiber specifically from fruits ... research has suggested // a connection between higher intake ... few studies have actually looked at the dietary fiber ... In a recent study researchers analyzed several studies to ...
... Being overweight in childhood can no longer be considered ... Recent study shows nearly 60 percent of overweight children ... ,The prevalence of type 2 diabetes is increasing ... the epidemic of type 2 diabetes in developing countries ...
... in the United States annually, and of these, 20 ... cell lung carcinoma (SCLC). Prognosis for these patients is ... and central nervous system. ,The probability of developing ... Whether or not these brain metastases directly impact mortality ...
Cached Medicine News:Health News:Childhood Weight Gain Found To Increase The Risk of Diabetes 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: